扩展现实在彻底改变神经疾病:慢性病治疗的新时代
Hariharan V1, Malini Prithiva Kumari Pk1, Rajanandh Mg1
1Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science and Technology, Chennai, IND.
Cureus
|September 24, 2024
概括
扩展现实 (XR) 为帕金森病 (PD) 和中风等神经系统疾病提供了沉浸式康复. 这项技术增强了运动和认知功能,通过引人入胜的练习和反来改善患者的结果.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 人与计算机的交互
背景情况:
- 慢性神经系统疾病 (帕金森病,多发性硬化症,阿尔茨海默氏症,中风) 带来了重大管理挑战.
- 传统的康复方法在参与和个性化方面存在局限性.
- 扩展现实 (XR) 技术,包括VR,AR和MR,提供了新的治疗途径.
研究的目的:
- 审查扩展现实 (XR) 对慢性神经系统疾病管理的影响.
- 突出XR在增强运动和认知康复方面的潜力.
- 讨论XR在神经护理中的挑战和未来方向.
主要方法:
- 对神经康复中XR应用的当前文献进行系统审查.
- 分析XR在运动和认知炼,神经可塑性和患者参与中的作用.
- 检查技术,临床验证和可访问性方面的考虑.
主要成果:
- XR为定制的运动和认知康复练习创造了沉浸式,交互式的环境.
- XR通过引人入胜,特定于背景的培训和实时反来促进神经可塑性.
- XR为神经疾病提供了传统治疗方法的创新替代方案.
结论:
- 射线 XR 技术显示出革命性神经康复和改善患者治疗结果的重大前景.
- 解决技术挑战,确保临床验证和改善可访问性对于广泛采用至关重要.
- 未来的研究应该专注于改进XR应用程序,与其他技术集成,并建立道德准则.
更多相关视频
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
1.2K
10:14Author Spotlight: Enhancing Neurorehabilitation Through EEG, Motor Imagery, and Virtual Reality
Published on: May 10, 2024
903
相关概念视频
Classification of Illness
9.4K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
9.4K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Chronic Bowel Disorders: Introduction
900
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
900
Drug Therapy
449
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
449
Multiple Sclerosis l: Introduction
20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
